Lupin first-quarter profit jumps 50% as US drug sales surge

MUMBAI (NewsRise) -- Indian drugmaker Lupin reported a 50% jump in first-quarter profit aided by a surge in sales in the U.S., where falling prices and rising competition had hurt demand for years.
